Inactive Instrument

Canopy Growth Corp Share Price Toronto S.E.

Equities

CGC

CA1380351009

Pharmaceuticals

End-of-day quote Toronto S.E.
- CAD - Intraday chart for Canopy Growth Corp

Financials

Sales 2024 344M 252M 20.96B Sales 2025 * 302M 221M 18.39B Capitalization 870M 638M 53.01B
Net income 2024 -657M -482M -40.04B Net income 2025 * -126M -92.43M -7.68B EV / Sales 2024 4.23 x
Net Debt 2024 394M 289M 24B Net Debt 2025 * 434M 319M 26.47B EV / Sales 2025 * 4.32 x
P/E ratio 2024
-1.33 x
P/E ratio 2025 *
-8.74 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99.73%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 60 01/18/01
Director of Finance/CFO 52 02/19/02
Investor Relations Contact - 01/16/01
Members of the board TitleAgeSince
Chief Executive Officer 60 01/18/01
Chairman 69 31/20/31
Director/Board Member 67 31/20/31
More insiders
Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The Company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. Its CPG portfolio includes gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. Its Rest-of-world cannabis segment includes the production, distribution, and sale of a diverse range of cannabis and hemp products internationally. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers.
More about the company